{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:14Z","timestamp":1788873194399,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-62807-6","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:48:28Z","timestamp":1784569708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enoxaparin induces apoptosis and autophagy, modulates inflammatory signaling, and reduces oxidative DNA damage in breast and liver cancer cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-5121","authenticated-orcid":false,"given":"Sedat","family":"Carkit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-1022","authenticated-orcid":false,"given":"M\u00fcnevver","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-9230","authenticated-orcid":false,"given":"Nazmiye","family":"Bitgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-9286","authenticated-orcid":false,"given":"Gozde Ozge","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-6574","authenticated-orcid":false,"given":"Damla","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-8372","authenticated-orcid":false,"given":"Arzu","family":"Yay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"10","key":"62807_CR1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1021\/bc200151q","volume":"22","author":"SS Kelkar","year":"2011","unstructured":"Kelkar, S. S. & Reineke, T. M. Theranostics: Combining imaging and therapy. Bioconjug. Chem. 22 (10), 1879\u20131903 (2011).","journal-title":"Bioconjug. Chem."},{"issue":"20","key":"62807_CR2","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.1039\/C5DT04781A","volume":"45","author":"K Purkait","year":"2016","unstructured":"Purkait, K., Chatterjee, S., Karmakar, S. & Mukherjee, A. Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru II-p-cymene complexes. Dalton Trans. 45 (20), 8541\u20138555 (2016).","journal-title":"Dalton Trans."},{"issue":"2","key":"62807_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1039\/C5DT04470G","volume":"45","author":"A Chandra","year":"2016","unstructured":"Chandra, A., Singh, K., Singh, S., Sivakumar, S. & Patra, A. K. A luminescent europium (III)\u2013platinum (II) heterometallic complex as a theranostic agent: A proof-of-concept study. Dalton Trans. 45 (2), 494\u2013497 (2016).","journal-title":"Dalton Trans."},{"issue":"12","key":"62807_CR4","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s, H., Rogers, M. S. & Straume, O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 8 (12), 5574\u20135576 (2019).","journal-title":"Cancer Med."},{"issue":"12","key":"62807_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle, M. & Hynes, R. O. The initial hours of metastasis: The importance of cooperative host\u2013tumor cell interactions during hematogenous dissemination. Cancer Discov. 2 (12), 1091\u20131099 (2012).","journal-title":"Cancer Discov."},{"issue":"5","key":"62807_CR6","doi-asserted-by":"publisher","first-page":"188770","DOI":"10.1016\/j.bbcan.2022.188770","volume":"1877","author":"K Morris","year":"2022","unstructured":"Morris, K., Schnoor, B. & Papa, A-L. Platelet cancer cell interplay as a new therapeutic target. Biochim.  Biophys. Acta (BBA)-Rev. Cancer 1877 (5), 188770 (2022).","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"1","key":"62807_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger, M. Role of platelets and platelet receptors in cancer metastasis. J. Hematol. Oncol. 11 (1), 125 (2018).","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"62807_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/026119299602400409","volume":"24","author":"H Seibert","year":"1996","unstructured":"Seibert, H. et al. Acute toxicity testing in vitro and the classification and labelling of chemicals: The report and recommendations of ECVAM Workshop 16. Altern. Lab. Anim. 24 (4), 499\u2013510 (1996).","journal-title":"Altern. Lab. Anim."},{"issue":"10","key":"62807_CR9","first-page":"1712","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp, J. F., Braekkan, S. K., Versteeg, H. H. & Cannegieter, S. C. Epidemiology of cancer-associated venous thrombosis. Blood J. Am. Soc. Hematol. 122 (10), 1712\u20131723 (2013).","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"5","key":"62807_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga, A. et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann. Oncol. 34 (5), 452\u2013467 (2023).","journal-title":"Ann. Oncol."},{"issue":"4","key":"62807_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2020","unstructured":"Konstantinides, S. V. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Heart J. 41 (4), 543\u2013603 (2020).","journal-title":"Eur. Heart J."},{"key":"62807_CR12","doi-asserted-by":"crossref","unstructured":"Lobo, J. L. et al. WITHDRAWN: Multidisciplinary consensus for the management of pulmonary thromboembolism. In Archivos de Bronconeumolog\u00eda (English Edition) (2021).","DOI":"10.1016\/j.arbr.2021.01.014"},{"issue":"19","key":"62807_CR13","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel, T. L. et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 4 (19), 4693\u20134738 (2020).","journal-title":"Blood Adv."},{"issue":"7","key":"62807_CR14","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge, D. et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 23 (7), e334\u2013e47 (2022).","journal-title":"Lancet Oncol."},{"issue":"1","key":"62807_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana, A. A. et al. Cancer-associated venous thromboembolism. Nat. Rev. Dis. Primers 8 (1), 11 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"62807_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.amjmed.2021.01.031","volume":"134","author":"AG Ording","year":"2021","unstructured":"Ording, A. G. et al. Increasing incidence and declining mortality after cancer-associated venous thromboembolism: A nationwide cohort study. Am. J. Med. 134 (7), 868\u2013876 (2021). e5.","journal-title":"Am. J. Med."},{"issue":"10","key":"62807_CR17","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","volume":"6","author":"TF Overvad","year":"2022","unstructured":"Overvad, T. F. et al. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy. Blood Adv. 6 (10), 2967\u20132976 (2022).","journal-title":"Blood Adv."},{"issue":"2","key":"62807_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","volume":"50","author":"JI Weitz","year":"2020","unstructured":"Weitz, J. I. et al. Cancer associated thrombosis in everyday practice: Perspectives from GARFIELD-VTE. J. Thromb. Thromb. 50 (2), 267\u2013277 (2020).","journal-title":"J. Thromb. Thromb."},{"key":"62807_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.72.e146759","volume":"72","author":"M Moneva-Sakelarieva","year":"2025","unstructured":"Moneva-Sakelarieva, M. et al. The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities. Pharmacia 72, 1\u201313 (2025).","journal-title":"Pharmacia"},{"issue":"1","key":"62807_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20100136","volume":"32","author":"G Sethi","year":"2012","unstructured":"Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P. & Tergaonkar, V. Multifaceted link between cancer and inflammation. Biosci. Rep. 32 (1), 1\u201315 (2012).","journal-title":"Biosci. Rep."},{"issue":"2","key":"62807_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/10590500902885684","volume":"27","author":"A Valavanidis","year":"2009","unstructured":"Valavanidis, A., Vlachogianni, T. & Fiotakis, C. 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health Part. C 27 (2), 120\u2013139 (2009).","journal-title":"J. Environ. Sci. Health Part. C"},{"issue":"5","key":"62807_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ehjcvp\/pvaa067","volume":"7","author":"A Elbadawi","year":"2021","unstructured":"Elbadawi, A., Shnoda, M., Mahmoud, K. & Elgendy, I. Y. Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: A meta-analysis of randomized trials. Eur. Heart J. Cardiovasc. Pharmacother. 7 (5), 380\u2013388 (2021).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"9","key":"62807_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/life13091888","volume":"13","author":"V Russo","year":"2023","unstructured":"Russo, V. et al. Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy. Life 13 (9), 1888 (2023).","journal-title":"Life"},{"key":"62807_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.01.023","volume":"165","author":"M Verso","year":"2022","unstructured":"Verso, M. et al. Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: An analysis of the Caravaggio study. Eur. J. Cancer 165, 136\u2013145 (2022).","journal-title":"Eur. J. Cancer"},{"key":"62807_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.sajb.2023.09.015","volume":"162","author":"M Baran","year":"2023","unstructured":"Baran, M., Bitgen, N., Onder, G. O., Gurbuz, P. & Yay, A. Cell proliferation, apoptosis and inflammation response of Melissa officinalis and Thymus vulgaris in SW480 colon cancer cells. S. Afr. J. Bot. 162, 282\u2013295 (2023).","journal-title":"S. Afr. J. Bot."},{"issue":"4","key":"62807_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/toxres\/tfad052","volume":"12","author":"N B\u0131tgen","year":"2023","unstructured":"B\u0131tgen, N., Onder, G. O., Baran, M. & Yay, A. Cytotoxicity screening of Thymus vulgaris L. in breast cancer: In vitro study. Toxicol. Res. 12 (4), 584\u2013590 (2023).","journal-title":"Toxicol. Res."},{"issue":"1","key":"62807_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdiacomp.2012.07.006","volume":"27","author":"M Morita","year":"2013","unstructured":"Morita, M., Yano, S., Yamaguchi, T. & Sugimoto, T. Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells. J. Diabetes Complic. 27 (1), 11\u201315 (2013).","journal-title":"J. Diabetes Complic."},{"issue":"5","key":"62807_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3727\/000000006783981053","volume":"16","author":"M Balzarotti","year":"2006","unstructured":"Balzarotti, M. et al. In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas. Oncol. Res. 16 (5), 245\u2013250 (2006).","journal-title":"Oncol. Res."},{"issue":"2","key":"62807_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1024\/0301-1526\/a000338","volume":"43","author":"VS Ellensen","year":"2014","unstructured":"Ellensen, V. S., Abrahamsen, I., Lorens, J. & Jonung, T. Effects of enoxaparin and dalteparin on proliferation and migration of patient-derived vascular smooth muscle cells. Vasa 43 (2), 124\u2013131 (2014).","journal-title":"Vasa"},{"issue":"9","key":"62807_CR30","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/cncr.26518","volume":"118","author":"J Ichikawa","year":"2012","unstructured":"Ichikawa, J. et al. Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: Procoagulant nature of osteosarcoma. Cancer 118 (9), 2494\u20132506 (2012).","journal-title":"Cancer"},{"issue":"12","key":"62807_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1160\/TH06-05-0289","volume":"96","author":"SA Mousa","year":"2006","unstructured":"Mousa, S. A., Linhardt, R., Francis, J. L. & Amirkhosravi, A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb. Haemost. 96 (12), 816\u2013821 (2006).","journal-title":"Thromb. Haemost."},{"issue":"7","key":"62807_CR32","doi-asserted-by":"publisher","first-page":"e41035","DOI":"10.1371\/journal.pone.0041035","volume":"7","author":"Q Niu","year":"2012","unstructured":"Niu, Q. et al. Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation. PLoS One. 7 (7), e41035 (2012).","journal-title":"PLoS One"},{"issue":"3","key":"62807_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1124\/mol.114.094425","volume":"87","author":"Y Pan","year":"2015","unstructured":"Pan, Y. et al. Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation. Mol. Pharmacol. 87 (3), 378\u2013390 (2015).","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"62807_CR34","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41375-025-02709-0","volume":"39","author":"C Yang","year":"2025","unstructured":"Yang, C. et al. Heat stress targets and degrades BCR:: ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia: Acute lymphoblastic leukemia. Leukemia 39 (9), 2140\u20132151 (2025).","journal-title":"Leukemia"},{"key":"62807_CR35","doi-asserted-by":"publisher","first-page":"0696","DOI":"10.34133\/research.0696","volume":"8","author":"P-H Yu","year":"2025","unstructured":"Yu, P-H., Zhu, C-Y., Kang, Y-Y., Naranmandura, H. & Yang, C. Mutation in the unrearranged PML allele confers resistance to arsenic trioxide in acute promyelocytic leukemia. Research 8, 0696 (2025).","journal-title":"Research"},{"issue":"10","key":"62807_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1139\/y11-068","volume":"89","author":"W Abu Arab","year":"2011","unstructured":"Abu Arab, W., Kotb, R., Sirois, M. & Rousseau, E. Concentration-and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro. Can. J. Physiol. Pharmacol. 89 (10), 705\u2013711 (2011).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"10","key":"62807_CR37","first-page":"625","volume":"70","author":"E Young","year":"1993","unstructured":"Young, E., Cosmi, B., Weitz, J. & Hirsh, J. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins. Thromb. Haemost. 70 (10), 625\u2013630 (1993).","journal-title":"Thromb. Haemost."},{"issue":"12","key":"62807_CR38","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou, V., Markaki, M., Palikaras, K. & Tavernarakis, N. Crosstalk between apoptosis, necrosis and autophagy. Biochim.  Biophys. Acta (BBA)-Mol. Cell. Res. 1833 (12), 3448\u20133459 (2013).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell. Res."},{"issue":"1","key":"62807_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1039\/C3IB40206A","volume":"6","author":"QY Lean","year":"2014","unstructured":"Lean, Q. Y., Patel, R. P., Stewart, N., Sohal, S. S. & Gueven, N. Identification of pro-and anti-proliferative oligosaccharides of heparins. Integr. Biol. 6 (1), 90\u201399 (2014).","journal-title":"Integr. Biol."},{"key":"62807_CR40","doi-asserted-by":"publisher","first-page":"548631","DOI":"10.3389\/fimmu.2020.548631","volume":"11","author":"E Rawish","year":"2020","unstructured":"Rawish, E., Nording, H., M\u00fcnte, T. & Langer, H. F. Platelets as mediators of neuroinflammation and thrombosis. Front. Immunol. 11, 548631 (2020).","journal-title":"Front. Immunol."},{"issue":"2 Part 1","key":"62807_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/AOG.0b013e3181ae6a08","volume":"114","author":"R-M Holst","year":"2009","unstructured":"Holst, R-M. et al. Prediction of spontaneous preterm delivery in women with preterm labor: Analysis of multiple proteins in amniotic and cervical fluids. Obstet. Gynecol. 114 (2 Part 1), 268\u2013277 (2009).","journal-title":"Obstet. Gynecol."},{"issue":"08","key":"62807_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-0030-1249366","volume":"27","author":"Y Sorokin","year":"2010","unstructured":"Sorokin, Y. et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth\u2009<\u200932 weeks and adverse neonatal outcomes. Am. J. Perinatol. 27 (08), 631\u2013640 (2010).","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"62807_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12929-018-0431-7","volume":"25","author":"TW Jung","year":"2018","unstructured":"Jung, T. W., Park, H. S., Choi, G. H., Kim, D. & Lee, T. \u03b2-Aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. J. Biomed. Sci. 25 (1), 27 (2018).","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"62807_CR44","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1002\/mco2.350","volume":"4","author":"K Liao","year":"2023","unstructured":"Liao, K. et al. The role of platelets in the regulation of tumor growth and metastasis: The mechanisms and targeted therapy. MedComm 4 (5), e350 (2023).","journal-title":"MedComm"},{"issue":"9","key":"62807_CR45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia, Y., Shen, S. & Verma, I. M. NF-\u03baB, an active player in human cancers. Cancer Immunol. Res. 2 (9), 823\u2013830 (2014).","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"62807_CR46","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus, A. & Ghosh, S. The NF-\u03baB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1 (4), a000034 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"62807_CR47","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S-C. NF-\u03baB signaling in inflammation. Signal. Transduct. Target. therapy. 2 (1), 1\u20139 (2017).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"62807_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biopha.2018.02.054","volume":"101","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Nepetin inhibits IL-1\u03b2 induced inflammation via NF-\u03baB and MAPKs signaling pathways in ARPE-19 cells. Biomed. Pharmacother. 101, 87\u201393 (2018).","journal-title":"Biomed. Pharmacother."},{"issue":"04","key":"62807_CR49","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1160\/TH12-08-0543","volume":"109","author":"Z Franks","year":"2013","unstructured":"Franks, Z. et al. Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb. Haemost. 109 (04), 684\u2013695 (2013).","journal-title":"Thromb. Haemost."},{"key":"62807_CR50","doi-asserted-by":"crossref","unstructured":"Tavares, V., Pinto, R., Assis, J., Pereira, D. & Medeiros, R. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour. Biochim. Biophys. Acta (BBA)-Rev. Cancer ;1873(1), 188331 (2020).","DOI":"10.1016\/j.bbcan.2019.188331"},{"issue":"9","key":"62807_CR51","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"Amaravadi, R. K., Kimmelman, A. C. & Debnath, J. Targeting autophagy in cancer: Recent advances and future directions. Cancer Discov. 9 (9), 1167\u20131181 (2019).","journal-title":"Cancer Discov."},{"issue":"3","key":"62807_CR52","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/mco2.150","volume":"3","author":"G Lu","year":"2022","unstructured":"Lu, G. et al. Autophagy in health and disease: From molecular mechanisms to therapeutic target. MedComm 3 (3), e150 (2022).","journal-title":"MedComm"},{"issue":"3","key":"62807_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41556-018-0042-2","volume":"20","author":"MD Rybstein","year":"2018","unstructured":"Rybstein, M. D., Bravo-San Pedro, J. M., Kroemer, G. & Galluzzi, L. The autophagic network and cancer. Nat. Cell Biol. 20 (3), 243\u2013251 (2018).","journal-title":"Nat. Cell Biol."},{"key":"62807_CR54","doi-asserted-by":"crossref","unstructured":"Tyutyunyk-Massey, L. & Gewirtz, D. A. (eds) Roles of Autophagy in Breast Cancer Treatment: Target, Bystander or Benefactor. Seminars in Cancer Biology (Elsevier, 2020).","DOI":"10.1016\/j.semcancer.2019.11.008"},{"key":"62807_CR55","doi-asserted-by":"publisher","first-page":"153465","DOI":"10.1016\/j.phymed.2021.153465","volume":"82","author":"X Fan","year":"2021","unstructured":"Fan, X. et al. Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK\/Akt\/mTOR pathway in ovarian cancer. Phytomedicine 82, 153465 (2021).","journal-title":"Phytomedicine"},{"issue":"14","key":"62807_CR56","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3390\/molecules24142644","volume":"24","author":"AV Markov","year":"2019","unstructured":"Markov, A. V. et al. Novel derivatives of deoxycholic acid bearing linear aliphatic diamine and aminoalcohol moieties and their cyclic analogs at the C3 position: Synthesis and evaluation of their in vitro antitumor potential. Molecules 24 (14), 2644 (2019).","journal-title":"Molecules"},{"issue":"1","key":"62807_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-023-01788-w","volume":"22","author":"R Entrialgo-Cadierno","year":"2023","unstructured":"Entrialgo-Cadierno, R. et al. The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer. Mol. Cancer. 22 (1), 86 (2023).","journal-title":"Mol. Cancer"},{"issue":"1","key":"62807_CR58","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1002\/ctm2.708","volume":"12","author":"L Fang","year":"2022","unstructured":"Fang, L. et al. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2-mediated autophagy. Clin. Transl. Med. 12 (1), e708 (2022).","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"62807_CR59","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","volume":"17","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy 17 (12), 4083\u20134101 (2021).","journal-title":"Autophagy"},{"issue":"9","key":"62807_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/1878-0261.13180","volume":"16","author":"JW Park","year":"2022","unstructured":"Park, J. W. et al. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR\u2010181a\u2010mediated regulation of ATG5 and\/or ATG2B. Mol. Oncol. 16 (9), 1857\u20131875 (2022).","journal-title":"Mol. Oncol."},{"key":"62807_CR61","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actbio.2022.04.017","volume":"145","author":"K Ren","year":"2022","unstructured":"Ren, K. et al. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis. Acta Biomater. 145, 185\u2013199 (2022).","journal-title":"Acta Biomater."},{"issue":"1","key":"62807_CR62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12943-024-02138-0","volume":"23","author":"K-J Ryu","year":"2024","unstructured":"Ryu, K-J. et al. Chaperone-mediated autophagy modulates snail protein stability: Implications for breast cancer metastasis. Mol. Cancer. 23 (1), 227 (2024).","journal-title":"Mol. Cancer"},{"issue":"8","key":"62807_CR63","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15548627.2021.2008752","volume":"18","author":"Y Xing","year":"2022","unstructured":"Xing, Y. et al. Autophagy inhibition mediated by MCOLN1\/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53\/p53 pathway. Autophagy 18 (8), 1932\u20131954 (2022).","journal-title":"Autophagy"},{"issue":"10","key":"62807_CR64","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.7150\/ijbs.85285","volume":"19","author":"M Ye","year":"2023","unstructured":"Ye, M. et al. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression. Int. J. Biol. Sci. 19 (10), 3115 (2023).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"62807_CR65","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4161\/auto.27344","volume":"10","author":"MH Sahani","year":"2014","unstructured":"Sahani, M. H., Itakura, E. & Mizushima, N. Expression of the autophagy substrate SQSTM1\/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy 10 (3), 431\u2013441 (2014).","journal-title":"Autophagy"},{"issue":"1","key":"62807_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev.pharmtox.44.101802.121851","volume":"44","author":"JE Klaunig","year":"2004","unstructured":"Klaunig, J. E. & Kamendulis, L. M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (1), 239\u2013267 (2004).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"62807_CR67","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/sageke.2005.9.re3","volume":"2005","author":"AM Skinner","year":"2005","unstructured":"Skinner, A. M. & Turker, M. S. Oxidative mutagenesis, mismatch repair, and aging. Sci. Aging Knowl. Environ. 2005 (9), re3\u2013re (2005).","journal-title":"Sci. Aging Knowl. Environ."},{"issue":"11","key":"62807_CR68","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun, C. W. & Lee, S. H. The roles of autophagy in cancer. Int. J. Mol. Sci. 19 (11), 3466 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"62807_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/jwh.2016.5973","volume":"26","author":"JD Lee","year":"2017","unstructured":"Lee, J. D., Cai, Q., Shu, X. O. & Nechuta, S. J. The role of biomarkers of oxidative stress in breast cancer risk and prognosis: A systematic review of the epidemiologic literature. J. Women\u2019s Health. 26 (5), 467\u2013482 (2017).","journal-title":"J. Women\u2019s Health"},{"issue":"3","key":"62807_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/diagnostics10030126","volume":"10","author":"S Shukla","year":"2020","unstructured":"Shukla, S. et al. Oxidative stress and antioxidant status in high-risk prostate cancer subjects. Diagnostics 10 (3), 126 (2020).","journal-title":"Diagnostics"},{"key":"62807_CR71","unstructured":"Hamidavi, A. et al. Lesion (8-hydroxydeoxyguanosine), 8-oxoguanine DNA glycosylase 1, and antioxidant status in Iranian patients diagnosed with high-grade oral squamous cell carcinoma. Oral Maxillofac. Pathol. J. 8(2) (2017)."},{"issue":"5A","key":"62807_CR72","first-page":"3403","volume":"26","author":"T Wada","year":"2006","unstructured":"Wada, T. et al. Mitochondrial DNA mutations and 8-hydroxy-2\u2032-deoxyguanosine content in Japanese patients with urinary bladder and renal cancers. Anticancer Res. 26 (5A), 3403\u20133408 (2006).","journal-title":"Anticancer Res."},{"issue":"1","key":"62807_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/em.1044","volume":"38","author":"MS Burger","year":"2001","unstructured":"Burger, M. S., Torino, J. L. & Swaminathan, S. DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl. Environ. Mol. Mutagen. 38 (1), 1\u201311 (2001).","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"62807_CR74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-3835(99)00424-3","volume":"151","author":"A Matsui","year":"2000","unstructured":"Matsui, A. et al. Increased formation of oxidative DNA damage, 8-hydroxy-2\u2032-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 151 (1), 87\u201395 (2000).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62807-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:03:35Z","timestamp":1788872615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62807-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62807-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28081"}}